Japan Cardiology Market is projected to grow significantly at a CAGR of around 6.5% during the ... .

Health Articles



Japan Cardiology Market

Japan Cardiology Market

Japan Cardiology Market is projected to grow significantly at a CAGR of around 6.5% during the forecast period. There are various factors that provide substantial growth at the Japan cardiology market including the availability of developed healthcare infrastructure and technological advancement in cardiology device technologies in the country. Japan is a technologically sound nation which is equipped with innovative methods for various heart surgeries.

Government of Japan initiated various awareness programs through the Japanese Society for Cardiovascular Surgery. The awareness level for heart diseases is increasing in Japan and the adoption of surgeries is also increasing at a modest rate. Various universities, R&D institutes, hospitals, and clinics are exploring cardiology surgeries through R&D to come up with innovative approaches and devices for cardiology surgeries.

To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/japan-cardiology-market

The market is segmented on the basis of device type, drug type, mechanism, and surgeries type. Based on Device type, the market is segregated angioplasty, cardiovascular stents, cardiovascular catheters, cardiac rhythm management, cardiovascular assistive devices. Angioplasty and vascular stenting are widely adopted procedures in the cardiology market and have a considerable market share.

Based on the drug type, the market is segmented into antithrombotic drugs, antidyslipidemic drugs, antihypertensive drugs, and anti-stroke drugs. On the basis of surgeries type, the market is classified into coronary artery bypass grafting, transmyocardial laser revascularization, heart valve repair, arrhythmia treatment, aneurysm repair, and heart transplant.

Japan Cardiology Market-Segmentation

By Device Type
• Angioplasty
• Cardiovascular stents
• Cardiovascular catheters
• Cardiac rhythm management
• Cardiovascular assistive devices
• Japan Cardiology Market by Mechanism
• Antithrombotic drugs
• Antidyslipidemic drugs
• Antihypertensive drugs
• Anti-stroke drugs

By Surgeries Type
• Beta blockers
• Beta agonists
• Alpha blockers
• Alpha agonists
• Sodium channel blockers
• Calcium channel blockers
• Vasodilators
• Renin inhibitors
• Angiotensin receptor blockers
• Diuretics
• Thrombolytics

By Drug Type
• Coronary artery bypass grafting
• Transmyocardial laser revascularization
• Heart valve repair
• Arrhythmia treatment
• Aneurysm repair
• Heart transplant

A full report of Japan Cardiology Market is available at: https://www.omrglobal.com/request-sample/japan-cardiology-market

Company Profiles

• Abbott Laboratories
• Terumo Corp.
• Daiichi Sankyo Co. Ltd.
• Otsuka Pharmaceutical Co., Ltd.
• Takeda Pharmaceutical Co., Ltd.
• Boston Scientific Corp.
• General Electric Co.
• Japan Lifeline Co., Ltd.
• Pfizer Inc.
• Hoffmann-La Roche Ltd.

For more customized data, request for report customization @ https://www.omrglobal.com/report-customization/japan-cardiology-market

Media Contact:
Company Name: Orion Market Reports
Contact Person: Mr. Anurag Tiwari
Email: info@orionmarketreports.com
Contact no: +1 646-755-7667, +91 780-304-0404

Orion Market Reports (OMR) endeavors to provide an exclusive blend of qualitative and quantitative market research reports to clients across the globe. Our organization helps both multinational and domestic enterprises to bolster their business by providing in-depth market insights and most reliable future market trends. Our reports address all the major aspects of the markets providing insights and market outlook to global clients.

This release was published on openPR.